News
On Thursday, the Google parent company (GOOGL) (GOOG) reported first-quarter earnings per share of $2.81, beating the FactSet consensus of $2.01, while revenue came in at $90.2 billion, beating ...
6hOpinion
AlterNet on MSN'Ultimate grifter': How Trump could drop his tariffs and take credit for saving economyPresident Trump is facing increasing criticism from big businesses over his decision to launch a global trade war. On Monday, ...
S&P 500's rapid exit from correction territory hinged on Trump's walk-backs of tariffs and Fed fight
The S&P 500 index SPX on Thursday was able to exit correction territory, ending at least 10% above its recent low set in the wake of President Donald Trump's April 2 "liberation day" tariffs. The ...
Lawrence G. McMillan is president of McMillan Analysis, a registered investment and commodity trading advisor. McMillan may hold positions in securities recommended in this report, both personally and ...
Stocks closed sharply higher for the third straight day on Thursday as investors reacted to a flurry of earnings reports from ...
Trump’s trade war continues to affect global markets as investors monitor the latest developments with China. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
“Ultimate Grifter”: Bob Kuttner on How Trump Could Drop His Tariffs & Take Credit for Saving Economy
President Trump is facing increasing criticism from big businesses over his decision to launch a global trade war. On Monday, ...
In his remarks, Gundlach calmly explained why the financial markets are currently bouncing around unpredictably. He and Bianco navigated the minefield of tariff-induced inflation and Europe's ...
Investors, traders and speculators continue to process the "known unknown" of global tariff-and-trade war negotiations.
Deutsche Bank's George Saravelos has been ringing the alarm bell about the U.S. dollar for some time, and now he's taking his concerns up another notch.
Shares of SpringWorks Therapeutics climbed after The Wall Street Journal reported that Germany's Merck KGaA is nearing a $3.5 billion deal for the U.S. biopharmaceutical company. SpringWorks stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results